Expression of concern
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
Paper Information
Record ID:
52502
Author(s):
Journal:
Publication Date:
February 04, 2008
Retraction Date:
February 28, 2024
(1.7 year years ago)
Subjects:
Institutions:
- Department of Cellular and Molecular Biology and Pathology, University of Naples Federico II, Naples, Italy
- Istituto di Endocrinologia ed Oncologia Sperimentale, CNR, IEOS, Naples, Italy
- Department of Molecular Virology, Immunology and Medical Genetics, Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
- Facolta` di Scienze Biotecnologiche, University of Naples Federico II, Naples, Italy
Countries:
Article Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1038/s41388-024-02989-3Citations (296)
296
Total Citations5
Post-Retraction(1.7%)
288
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
497
Days since retraction (latest)
Epigenetic Control of Tumor Suppressor Genes in Lung Cancer
Xuan Qiu, Román Pérez-Soler, Yiyu Zou
InTech eBooks
Open Access
Published: Feb 2012
4408 days before retraction
Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer
Luis Martínez‐Lostao, Isabel Marzo, Alberto Anel et al. (4 authors)
Biochemical Pharmacology
Published: Jan 2012
51 citations
51 citations
4440 days before retraction
miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
Michela Garofalo, Cristina Quintavalle, Giulia Romano et al. (5 authors)
Current Molecular Medicine
Open Access
Published: Dec 2011
321 citations
321 citations
4468 days before retraction
The altered expression of MiR‐221/‐222 and MiR‐23b/‐27b is associated with the development of human castration resistant prostate cancer
Tong Sun, Ming Yang, Shaoyong Chen et al. (9 authors)
The Prostate
Open Access
Published: Nov 2011
94 citations
94 citations
4474 days before retraction
Epigenetic Regulation of miR-212 Expression in Lung Cancer
Mariarosaria Incoronato, Loredana Urso, Anna Portela et al. (9 authors)
PLoS ONE
Open Access
Published: Nov 2011
78 citations
78 citations
4488 days before retraction
Anti-microRNA-222 (Anti-miR-222) and -181B Suppress Growth of Tamoxifen-resistant Xenografts in Mouse by Targeting TIMP3 Protein and Modulating Mitogenic Signal
Yuanzhi Lu, Satavisha Roy, Gerard J. Nuovo et al. (8 authors)
Journal of Biological Chemistry
Open Access
Published: Oct 2011
103 citations
103 citations
4515 days before retraction
Molecular Biology of Lung Cancer: Clinical Implications
Jill E. Larsen, John D. Minna
Clinics in Chest Medicine
Open Access
Published: Oct 2011
225 citations
225 citations
4519 days before retraction
Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells
Jing Zhao, Yixin Lü, Han‐Ming Shen
Cancer Letters
Published: Oct 2011
71 citations
71 citations
4520 days before retraction
Big roles of microRNAs in tumorigenesis and tumor development.
Jun Tie, Daiming Fan
PubMed
Published: Oct 2011
52 citations
52 citations
4533 days before retraction
microRNAs, an active and versatile group in cancers
Jeffrey Liu, Min Zheng, Yaling Tang et al. (5 authors)
International Journal of Oral Science
Open Access
Published: Oct 2011
65 citations
65 citations
4533 days before retraction
MicroRNAs and drug modulation in cancer: an intertwined new story
Francesca Fanini, Ivan Vannini, Muller Fabbri
Frontiers in Biology
Published: Sep 2011
1 citation
1 citation
4534 days before retraction
MiR-221/222 Promote the Growth of Malignant Glioma Cells by Regulating Its Target Genes
Zhang Chun-zhi, Tao Jiang, Jinhuan Wang et al. (6 authors)
InTech eBooks
Open Access
Published: Sep 2011
4542 days before retraction
miRNAs in Lung Cancer: Large Roles for Small Players
Irene Cherni, Glen J. Weiss
Future Oncology
Published: Sep 2011
32 citations
32 citations
4549 days before retraction
“Fishing” for endothelial microRNA functions and dysfunction
Massimo Santoro
Vascular Pharmacology
Published: Sep 2011
11 citations
11 citations
4555 days before retraction
Plasma microRNAs as novel biomarkers for early detection of lung cancer.
Dali Zheng, Shadi Haddadin, Yong Wang et al. (7 authors)
PubMed
Published: Aug 2011
252 citations
252 citations
4580 days before retraction
miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ
Cristina Quintavalle, Michela Garofalo, Ciro Zanca et al. (11 authors)
Oncogene
Open Access
Published: Jul 2011
169 citations
169 citations
4615 days before retraction
MicroRNAs, diet, and cancer: New mechanistic insights on the epigenetic actions of phytochemicals
Mansi Parasramka, Emily Ho, David E. Williams et al. (4 authors)
Molecular Carcinogenesis
Open Access
Published: Jul 2011
114 citations
114 citations
4619 days before retraction
MicroRNAs in Development and Disease
Danish Sayed, Maha Abdellatif
Physiological Reviews
Published: Jul 2011
1054 citations
1054 citations
4625 days before retraction
miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
Mario Acunzo, Rosa Visone, Giulia Romano et al. (12 authors)
Oncogene
Open Access
Published: Jun 2011
190 citations
190 citations
4629 days before retraction
TLR9 agonist enhances lung cancer invasiveness by alternating miRNA expression profile
Tao Ren, Xiaoye He, Ying-yun Cai et al. (4 authors)
Scientific Research and Essays
Published: Jun 2011
2 citations
2 citations
4638 days before retraction
Identification of ten serum microRNAs from a genome‐wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis
Xi Chen, Zhibin Hu, Wenjing Wang et al. (20 authors)
International Journal of Cancer
Open Access
Published: May 2011
277 citations
277 citations
4678 days before retraction
Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
Elisa Giovannetti, Ayse Erozenci, Jorn Smit et al. (5 authors)
Critical Reviews in Oncology/Hematology
Published: May 2011
193 citations
193 citations
4678 days before retraction
Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer
Niels H. H. Heegaard, Aaron J. Schetter, Judith A. Welsh et al. (6 authors)
International Journal of Cancer
Open Access
Published: May 2011
284 citations
284 citations
4683 days before retraction
MicroRNA in lung cancer diagnostics and treatment
Marcin Skrzypski, Rafał Dziadziuszko, Jacek Jassem
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
Published: Apr 2011
52 citations
52 citations
4695 days before retraction
Implications of miRNA-directed Gene Silencing in Cance
Duncan Ayers
CRC Press eBooks
Published: Apr 2011
4697 days before retraction
Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis
Evelien W. Duiker, Annemieke Meijer, Arne R.M. van der Bilt et al. (8 authors)
British Journal of Cancer
Open Access
Published: Apr 2011
42 citations
42 citations
4716 days before retraction
A novel microRNA mmu‐miR‐466h affects apoptosis regulation in mammalian cells
Aliaksandr Druz, Chia Chu, Brian S. Majors et al. (6 authors)
Biotechnology and Bioengineering
Open Access
Published: Feb 2011
86 citations
86 citations
4759 days before retraction
microRNAs: Master Regulators as Potential Therapeutics in Cancer
Michela Garofalo, Carlo M. Croce
The Annual Review of Pharmacology and Toxicology
Published: Jan 2011
285 citations
285 citations
4801 days before retraction
MicroRNA-23a: A Novel Serum Based Diagnostic Biomarker for Lung Adenocarcinoma
Yu Mi Lee, Hyun-Jung Cho, Soo Young Lee et al. (11 authors)
Tuberculosis & respiratory diseases
Open Access
Published: Jan 2011
12 citations
12 citations
4806 days before retraction
Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer
Athina Markou, Yu Liang, Evi Lianidou
Clinical Chemistry and Laboratory Medicine (CCLM)
Published: Jan 2011
52 citations
52 citations
4806 days before retraction
Circulating MicroRNAs: Possible Prediction Biomarkers for Personalized Therapy of Non–Small-Cell Lung Carcinoma
Wen Gao, Lingxiang Liu, Xiao Lu et al. (4 authors)
Clinical Lung Cancer
Published: Jan 2011
38 citations
38 citations
4806 days before retraction
Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes
Geula Hanin, Hermona Soreq
Frontiers in Molecular Neuroscience
Open Access
Published: Jan 2011
36 citations
36 citations
4806 days before retraction
Role of MicroRNAs in Anti-cancer Drug Resistance
Erik A.C. Wiemer
Springer eBooks
Published: Dec 2010
5 citations
5 citations
4824 days before retraction
MicroRNA regulation of core apoptosis pathways in cancer
Raquel T. Lima, Sara Busacca, Gabriela M. Almeida et al. (6 authors)
European Journal of Cancer
Published: Dec 2010
260 citations
260 citations
4829 days before retraction
PUMA is a novel target of miR-221/222 in human epithelial cancers
Chunsheng Kang
International Journal of Oncology
Open Access
Published: Oct 2010
109 citations
109 citations
4877 days before retraction
Expression Profile of MicroRNAs in Serum: A Fingerprint for Esophageal Squamous Cell Carcinoma
Chen‐Yu Zhang, Cheng Wang, Xi Chen et al. (19 authors)
Clinical Chemistry
Open Access
Published: Oct 2010
300 citations
300 citations
4885 days before retraction
TRAIL receptor signaling and therapeutics
Junaid Abdulghani, Wafik S. El‐Deiry
Expert Opinion on Therapeutic Targets
Published: Sep 2010
157 citations
157 citations
4922 days before retraction
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
Zhiwei Wang, Yiwei Li, Aamir Ahmad et al. (7 authors)
Drug Resistance Updates
Open Access
Published: Aug 2010
337 citations
337 citations
4959 days before retraction
Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
Prashant Bavi, Sarita Prabhakaran, Jehad Abubaker et al. (13 authors)
Molecular Cancer
Open Access
Published: Jul 2010
25 citations
25 citations
4961 days before retraction
Uterine microRNA signature and consequence of their dysregulation in uterine disorders.
Nasser Chegini
PubMed
Published: Jul 2010
17 citations
17 citations
4990 days before retraction
MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs
Liqin Du, Jeoffrey Schageman, Irnov Irnov et al. (8 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Jun 2010
66 citations
66 citations
5004 days before retraction
c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity
C Quintavalle, Mariarosaria Incoronato, Loredana Puca et al. (10 authors)
Cell Death and Differentiation
Open Access
Published: May 2010
23 citations
23 citations
5024 days before retraction
Small molecules with big effects: The role of the microRNAome in cancer and carcinogenesis
Igor Koturbash, Franz J. Zemp, Igor P. Pogribny et al. (4 authors)
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
Published: May 2010
120 citations
120 citations
5030 days before retraction
Roles of small RNAs in tumor formation
Gianpiero Di Leva, Carlo M. Croce
Trends in Molecular Medicine
Open Access
Published: May 2010
257 citations
257 citations
5031 days before retraction
MicroRNA and drug resistance
Junxia Ma, Chun‐Juan Dong, C Ji
Cancer Gene Therapy
Published: May 2010
299 citations
299 citations
5038 days before retraction
miR-212 Increases Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Sensitivity in Non–Small Cell Lung Cancer by Targeting the Antiapoptotic Protein PED
Mariarosaria Incoronato, Michela Garofalo, Loredana Urso et al. (10 authors)
Cancer Research
Open Access
Published: Apr 2010
134 citations
134 citations
5068 days before retraction
MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer
Gianpiero Di Leva, Pierluigi Gasparini, Claudia Piovan et al. (15 authors)
JNCI Journal of the National Cancer Institute
Open Access
Published: Apr 2010
307 citations
307 citations
5068 days before retraction
[MicroRNA and lung cancer].
Xiaoxiao Niu, Qinqin Wang
PubMed
Published: Apr 2010
1 citation
1 citation
5081 days before retraction
Implication of microRNAs in drug resistance for designing novel cancer therapy
Fazlul H. Sarkar, Yiwei Li, Zhiwei Wang et al. (5 authors)
Drug Resistance Updates
Open Access
Published: Mar 2010
207 citations
207 citations
5095 days before retraction
Quick Stats
Total Citations:
296
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025